Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A CD56‐negative case of blastic natural killer‐cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm)

Identifieur interne : 000F85 ( Istex/Corpus ); précédent : 000F84; suivant : 000F86

A CD56‐negative case of blastic natural killer‐cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm)

Auteurs : T. Petrella ; M. A. Teitell ; C. Spiekermann ; C. J. L. M. Meijer ; F. Franck ; I. Enache

Source :

RBID : ISTEX:F3844CBE1D15EA603339F7C3304503BF5D105C79

English descriptors


Url:
DOI: 10.1111/j.1365-2133.2004.05713.x

Links to Exploration step

ISTEX:F3844CBE1D15EA603339F7C3304503BF5D105C79

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A CD56‐negative case of blastic natural killer‐cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm)</title>
<author>
<name sortKey="Petrella, T" sort="Petrella, T" uniqKey="Petrella T" first="T." last="Petrella">T. Petrella</name>
<affiliation>
<mods:affiliation>Centre de Pathologie, 33 Rue Nicolas Bornier, BP 189, and Laboratoire d'Anatomie Pathologique (Centre Hospitalo‐Universitaire), Dijon 21000, France, Departments of Pathology and Pediatrics, Center for Cell Mimetic Studies (CMISE), Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095‐1732, U.S.A.</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Teitell, M A" sort="Teitell, M A" uniqKey="Teitell M" first="M. A." last="Teitell">M. A. Teitell</name>
<affiliation>
<mods:affiliation>Centre de Pathologie, 33 Rue Nicolas Bornier, BP 189, and Laboratoire d'Anatomie Pathologique (Centre Hospitalo‐Universitaire), Dijon 21000, France, Departments of Pathology and Pediatrics, Center for Cell Mimetic Studies (CMISE), Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095‐1732, U.S.A.</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Spiekermann, C" sort="Spiekermann, C" uniqKey="Spiekermann C" first="C." last="Spiekermann">C. Spiekermann</name>
<affiliation>
<mods:affiliation>Pathology</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Meijer, C J L M" sort="Meijer, C J L M" uniqKey="Meijer C" first="C. J. L. M." last="Meijer">C. J. L. M. Meijer</name>
<affiliation>
<mods:affiliation>Department of Pathology, Vrije Universiteit Medical Centre, Amsterdam 1007MB, the Netherlands</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Franck, F" sort="Franck, F" uniqKey="Franck F" first="F." last="Franck">F. Franck</name>
<affiliation>
<mods:affiliation>Department of Pathology, Hotel Dieu, Clermont‐Ferrand 63000, France E‐mail: tony.petrella@centre‐de‐pathologie.fr</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Enache, I" sort="Enache, I" uniqKey="Enache I" first="I." last="Enache">I. Enache</name>
<affiliation>
<mods:affiliation>Internal Medicine, Centre Hospitalier Régional, Nevers 58000, France</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F3844CBE1D15EA603339F7C3304503BF5D105C79</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1111/j.1365-2133.2004.05713.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-73SRQHV7-W/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000F85</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F85</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">A CD56‐negative case of blastic natural killer‐cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm)</title>
<author>
<name sortKey="Petrella, T" sort="Petrella, T" uniqKey="Petrella T" first="T." last="Petrella">T. Petrella</name>
<affiliation>
<mods:affiliation>Centre de Pathologie, 33 Rue Nicolas Bornier, BP 189, and Laboratoire d'Anatomie Pathologique (Centre Hospitalo‐Universitaire), Dijon 21000, France, Departments of Pathology and Pediatrics, Center for Cell Mimetic Studies (CMISE), Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095‐1732, U.S.A.</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Teitell, M A" sort="Teitell, M A" uniqKey="Teitell M" first="M. A." last="Teitell">M. A. Teitell</name>
<affiliation>
<mods:affiliation>Centre de Pathologie, 33 Rue Nicolas Bornier, BP 189, and Laboratoire d'Anatomie Pathologique (Centre Hospitalo‐Universitaire), Dijon 21000, France, Departments of Pathology and Pediatrics, Center for Cell Mimetic Studies (CMISE), Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095‐1732, U.S.A.</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Spiekermann, C" sort="Spiekermann, C" uniqKey="Spiekermann C" first="C." last="Spiekermann">C. Spiekermann</name>
<affiliation>
<mods:affiliation>Pathology</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Meijer, C J L M" sort="Meijer, C J L M" uniqKey="Meijer C" first="C. J. L. M." last="Meijer">C. J. L. M. Meijer</name>
<affiliation>
<mods:affiliation>Department of Pathology, Vrije Universiteit Medical Centre, Amsterdam 1007MB, the Netherlands</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Franck, F" sort="Franck, F" uniqKey="Franck F" first="F." last="Franck">F. Franck</name>
<affiliation>
<mods:affiliation>Department of Pathology, Hotel Dieu, Clermont‐Ferrand 63000, France E‐mail: tony.petrella@centre‐de‐pathologie.fr</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Enache, I" sort="Enache, I" uniqKey="Enache I" first="I." last="Enache">I. Enache</name>
<affiliation>
<mods:affiliation>Internal Medicine, Centre Hospitalier Régional, Nevers 58000, France</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">British Journal of Dermatology</title>
<title level="j" type="alt">BRITISH JOURNAL OF DERMATOLOGY</title>
<idno type="ISSN">0007-0963</idno>
<idno type="eISSN">1365-2133</idno>
<imprint>
<biblScope unit="vol">150</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="174">174</biblScope>
<biblScope unit="page" to="176">176</biblScope>
<biblScope unit="page-count">3</biblScope>
<publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2004-01">2004-01</date>
</imprint>
<idno type="ISSN">0007-0963</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0007-0963</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Abdominal pain</term>
<term>Acad</term>
<term>Acad dermatol</term>
<term>Acral osteolysis</term>
<term>Acral ulcerations</term>
<term>Adult patients</term>
<term>Angiosarcoma</term>
<term>Angiosarcoma patients</term>
<term>Anticoagulant therapy</term>
<term>Antinuclear antibodies</term>
<term>Arch dermatol</term>
<term>Atrophic plaques</term>
<term>Azathioprine</term>
<term>Basement membrane zone</term>
<term>Basilar region</term>
<term>Biopsy</term>
<term>Blastic</term>
<term>Blastic lymphoma</term>
<term>Blood serology</term>
<term>Bone densitometry</term>
<term>Bone marrow</term>
<term>British association</term>
<term>British journal</term>
<term>Brosing dermopathy</term>
<term>Brown macules</term>
<term>Bullous reaction</term>
<term>Calcinosis</term>
<term>Calcinosis cutis</term>
<term>Calculus</term>
<term>Canal carpien</term>
<term>Captopril</term>
<term>Carpal</term>
<term>Carpal tunnel syndrome</term>
<term>Case report</term>
<term>Cefpodoxime proxetil</term>
<term>Cellulitis</term>
<term>Centre</term>
<term>Clinical course</term>
<term>Clinical features</term>
<term>Clinical practice</term>
<term>Common cutaneous</term>
<term>Complement components</term>
<term>Complete remission</term>
<term>Contact dermatitis</term>
<term>Correspondence figure</term>
<term>Cutaneous</term>
<term>Cutis</term>
<term>Cytoplasmic expression</term>
<term>Daily number</term>
<term>Danazol</term>
<term>Danazol treatment</term>
<term>David geffen school</term>
<term>Deep skin necrosis</term>
<term>Dermal</term>
<term>Dermal dendrocytes</term>
<term>Dermal papillae</term>
<term>Dermatol</term>
<term>Dermatologist</term>
<term>Dermatology</term>
<term>Dermis</term>
<term>Dystrophic calcinosis cutis</term>
<term>Environmental temperature</term>
<term>Epidermal</term>
<term>Epidermal keratinocytes</term>
<term>Epidermal keratins</term>
<term>Epidermis</term>
<term>Eruption</term>
<term>Eruptive</term>
<term>Erythema</term>
<term>Erythema multiforme</term>
<term>Erythematosus</term>
<term>Erythematous</term>
<term>Exogenous oestrogens</term>
<term>Factor xiiia</term>
<term>Foam cells</term>
<term>Foamy cells</term>
<term>Forearm injury</term>
<term>Generalized eruptive histiocytoma</term>
<term>Generalized eruptive histiocytosis</term>
<term>Genital</term>
<term>Genital lesions</term>
<term>Genital mucosa</term>
<term>Granular cell layer</term>
<term>Growth factor</term>
<term>Haematodermic neoplasm</term>
<term>Haemorrhagic cystitis</term>
<term>Hair follicle</term>
<term>Hepatitis</term>
<term>Hereditary angioedema</term>
<term>Herpes</term>
<term>Herpes zoster</term>
<term>Histiocytosis</term>
<term>Hospital admission</term>
<term>Hydroxychloroquine</term>
<term>Hydroxychloroquine sulphate</term>
<term>Immunol lett</term>
<term>Important role</term>
<term>Infectious diseases</term>
<term>Inhibitor</term>
<term>Inner right thigh</term>
<term>Internal medicine</term>
<term>Isotretinoin</term>
<term>Italy references</term>
<term>Keratinizing differentiation</term>
<term>Keratinocytes</term>
<term>Kitasato university school</term>
<term>Labia majora</term>
<term>Lesion</term>
<term>Lesional biopsy</term>
<term>Lichen</term>
<term>Lichen planus</term>
<term>Lichen sclerosus</term>
<term>Lisinopril</term>
<term>Liver kidney</term>
<term>Localized scleroderma</term>
<term>Long history</term>
<term>Lower extremities</term>
<term>Lupus erythematosus</term>
<term>Lymphatic</term>
<term>Lymphatic vessels</term>
<term>Lymphocyte</term>
<term>Lymphoma</term>
<term>Malignant</term>
<term>Many tumours</term>
<term>Maximum temperature</term>
<term>Median</term>
<term>Median nerve</term>
<term>Median nerves</term>
<term>Medical dermatology</term>
<term>Molecular defect</term>
<term>Mucin deposits</term>
<term>Mucinosis</term>
<term>Neoplasm</term>
<term>Nephrogenic fibrosing dermopathy</term>
<term>Ngers</term>
<term>Nonparametric poisson regression model</term>
<term>Normal amount</term>
<term>Normal controls</term>
<term>Normal range</term>
<term>Normal values</term>
<term>Oral contraception</term>
<term>Oral isotretinoin</term>
<term>Oral pathol</term>
<term>Outermost surface</term>
<term>Overlap syndrome</term>
<term>Palo alto</term>
<term>Papillomatous surface</term>
<term>Papule</term>
<term>Pathol</term>
<term>Peculiar type</term>
<term>Pediatr dermatol</term>
<term>Pemphigus</term>
<term>Pemphigus erythematosus</term>
<term>Pemphigus vulgaris</term>
<term>Pilot study</term>
<term>Pinkish erythematous papules</term>
<term>Planus</term>
<term>Plaque</term>
<term>Plasmacytoid dendritic cells</term>
<term>Present case</term>
<term>Present study</term>
<term>Prominent areas</term>
<term>Prominent skin symptoms</term>
<term>Range years</term>
<term>Rare disease</term>
<term>Relapse</term>
<term>Relapse biopsies</term>
<term>Renal</term>
<term>Renal dialysis</term>
<term>Renal disease</term>
<term>Renal transplant</term>
<term>Residual keratinocytes</term>
<term>Respective time points</term>
<term>Reticular</term>
<term>Reticular erythematous mucinosis</term>
<term>Reticular erythematous mucinosis syndrome</term>
<term>Rheumatoid arthritis</term>
<term>Right hand</term>
<term>Right index</term>
<term>Right side</term>
<term>Right subauricular region</term>
<term>Sarcoma</term>
<term>Sclerosus</term>
<term>Seasonal factors</term>
<term>Sertraline</term>
<term>Serum levels</term>
<term>Serum protein levels</term>
<term>Severe form</term>
<term>Severe multicentric reticulohistiocytosis</term>
<term>Skin biopsy</term>
<term>Skin lesions</term>
<term>Skin necrosis</term>
<term>Small number</term>
<term>Squamous cell carcinoma</term>
<term>Steroid</term>
<term>Subcutaneous mass</term>
<term>Supraclavicular region</term>
<term>Surface irregularity</term>
<term>Surg pathol</term>
<term>Surgical</term>
<term>Surgical decompression</term>
<term>Surgical removal</term>
<term>Syndrome</term>
<term>Systemic</term>
<term>Systemic administration</term>
<term>Systemic antimalarials</term>
<term>Systemic sclerosis</term>
<term>Tacrolimus</term>
<term>Tacrolimus ointment</term>
<term>Temporal scalp</term>
<term>Therapeutic effect</term>
<term>Third case</term>
<term>Tissue damage</term>
<term>Topical tacrolimus</term>
<term>Trichilemmal</term>
<term>Trichilemmal cyst</term>
<term>Trichilemmal keratinization</term>
<term>Trichilemmal tumor</term>
<term>Trichilemmal tumour</term>
<term>Tumour</term>
<term>Tumour cells</term>
<term>Tumour expansion</term>
<term>Tumour stage</term>
<term>Ulceration</term>
<term>Urine</term>
<term>Urine analysis</term>
<term>Vaginal calculi</term>
<term>Various sizes</term>
<term>Verruciform</term>
<term>Verruciform xanthoma</term>
<term>Virus infection</term>
<term>Warfarin</term>
<term>World health organisation</term>
<term>Xanthoma</term>
<term>Xanthomatous cells</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<keywords>
<teeft>
<json:string>dermatology</json:string>
<json:string>dermatol</json:string>
<json:string>tumour</json:string>
<json:string>dermatologist</json:string>
<json:string>british association</json:string>
<json:string>british journal</json:string>
<json:string>erythematous</json:string>
<json:string>lichen</json:string>
<json:string>cutaneous</json:string>
<json:string>cellulitis</json:string>
<json:string>warfarin</json:string>
<json:string>isotretinoin</json:string>
<json:string>carpal</json:string>
<json:string>sarcoma</json:string>
<json:string>angiosarcoma</json:string>
<json:string>dermis</json:string>
<json:string>ngers</json:string>
<json:string>verruciform</json:string>
<json:string>dermal</json:string>
<json:string>neoplasm</json:string>
<json:string>keratinocytes</json:string>
<json:string>danazol</json:string>
<json:string>xanthoma</json:string>
<json:string>pemphigus</json:string>
<json:string>trichilemmal</json:string>
<json:string>carpal tunnel syndrome</json:string>
<json:string>lisinopril</json:string>
<json:string>reticular</json:string>
<json:string>verruciform xanthoma</json:string>
<json:string>blastic</json:string>
<json:string>planus</json:string>
<json:string>sertraline</json:string>
<json:string>acad</json:string>
<json:string>ulceration</json:string>
<json:string>acad dermatol</json:string>
<json:string>lesion</json:string>
<json:string>relapse</json:string>
<json:string>epidermal</json:string>
<json:string>calcinosis</json:string>
<json:string>lichen planus</json:string>
<json:string>pathol</json:string>
<json:string>oral isotretinoin</json:string>
<json:string>malignant</json:string>
<json:string>captopril</json:string>
<json:string>cutis</json:string>
<json:string>tacrolimus</json:string>
<json:string>papule</json:string>
<json:string>histiocytosis</json:string>
<json:string>erythematosus</json:string>
<json:string>azathioprine</json:string>
<json:string>genital</json:string>
<json:string>mucinosis</json:string>
<json:string>syndrome</json:string>
<json:string>tumour cells</json:string>
<json:string>lymphatic</json:string>
<json:string>herpes</json:string>
<json:string>eruptive</json:string>
<json:string>hydroxychloroquine</json:string>
<json:string>sclerosus</json:string>
<json:string>lymphocyte</json:string>
<json:string>erythema</json:string>
<json:string>calculus</json:string>
<json:string>renal</json:string>
<json:string>present case</json:string>
<json:string>angiosarcoma patients</json:string>
<json:string>arch dermatol</json:string>
<json:string>normal controls</json:string>
<json:string>daily number</json:string>
<json:string>pemphigus erythematosus</json:string>
<json:string>danazol treatment</json:string>
<json:string>growth factor</json:string>
<json:string>herpes zoster</json:string>
<json:string>lichen sclerosus</json:string>
<json:string>reticular erythematous mucinosis</json:string>
<json:string>foamy cells</json:string>
<json:string>biopsy</json:string>
<json:string>lymphoma</json:string>
<json:string>steroid</json:string>
<json:string>surgical</json:string>
<json:string>right hand</json:string>
<json:string>present study</json:string>
<json:string>contact dermatitis</json:string>
<json:string>serum levels</json:string>
<json:string>generalized eruptive histiocytosis</json:string>
<json:string>foam cells</json:string>
<json:string>complement components</json:string>
<json:string>environmental temperature</json:string>
<json:string>skin lesions</json:string>
<json:string>inhibitor</json:string>
<json:string>median</json:string>
<json:string>urine</json:string>
<json:string>mucin deposits</json:string>
<json:string>factor xiiia</json:string>
<json:string>complete remission</json:string>
<json:string>acral ulcerations</json:string>
<json:string>respective time points</json:string>
<json:string>lower extremities</json:string>
<json:string>maximum temperature</json:string>
<json:string>epidermal keratinocytes</json:string>
<json:string>systemic antimalarials</json:string>
<json:string>median nerve</json:string>
<json:string>canal carpien</json:string>
<json:string>topical tacrolimus</json:string>
<json:string>dermal dendrocytes</json:string>
<json:string>immunol lett</json:string>
<json:string>rheumatoid arthritis</json:string>
<json:string>overlap syndrome</json:string>
<json:string>antinuclear antibodies</json:string>
<json:string>dermal papillae</json:string>
<json:string>prominent areas</json:string>
<json:string>outermost surface</json:string>
<json:string>basilar region</json:string>
<json:string>haematodermic neoplasm</json:string>
<json:string>calcinosis cutis</json:string>
<json:string>tissue damage</json:string>
<json:string>clinical course</json:string>
<json:string>important role</json:string>
<json:string>squamous cell carcinoma</json:string>
<json:string>tumour stage</json:string>
<json:string>skin biopsy</json:string>
<json:string>trichilemmal tumour</json:string>
<json:string>generalized eruptive histiocytoma</json:string>
<json:string>tumour expansion</json:string>
<json:string>right subauricular region</json:string>
<json:string>surg pathol</json:string>
<json:string>internal medicine</json:string>
<json:string>blastic lymphoma</json:string>
<json:string>plaque</json:string>
<json:string>eruption</json:string>
<json:string>epidermis</json:string>
<json:string>systemic</json:string>
<json:string>subcutaneous mass</json:string>
<json:string>basement membrane zone</json:string>
<json:string>lymphatic vessels</json:string>
<json:string>molecular defect</json:string>
<json:string>range years</json:string>
<json:string>pemphigus vulgaris</json:string>
<json:string>abdominal pain</json:string>
<json:string>surface irregularity</json:string>
<json:string>normal values</json:string>
<json:string>anticoagulant therapy</json:string>
<json:string>cefpodoxime proxetil</json:string>
<json:string>therapeutic effect</json:string>
<json:string>italy references</json:string>
<json:string>bullous reaction</json:string>
<json:string>skin necrosis</json:string>
<json:string>serum protein levels</json:string>
<json:string>hair follicle</json:string>
<json:string>deep skin necrosis</json:string>
<json:string>temporal scalp</json:string>
<json:string>localized scleroderma</json:string>
<json:string>erythema multiforme</json:string>
<json:string>systemic administration</json:string>
<json:string>normal range</json:string>
<json:string>systemic sclerosis</json:string>
<json:string>right index</json:string>
<json:string>normal amount</json:string>
<json:string>kitasato university school</json:string>
<json:string>oral contraception</json:string>
<json:string>severe form</json:string>
<json:string>long history</json:string>
<json:string>exogenous oestrogens</json:string>
<json:string>forearm injury</json:string>
<json:string>surgical decompression</json:string>
<json:string>median nerves</json:string>
<json:string>hereditary angioedema</json:string>
<json:string>nonparametric poisson regression model</json:string>
<json:string>surgical removal</json:string>
<json:string>acral osteolysis</json:string>
<json:string>bone marrow</json:string>
<json:string>prominent skin symptoms</json:string>
<json:string>right side</json:string>
<json:string>brosing dermopathy</json:string>
<json:string>third case</json:string>
<json:string>genital lesions</json:string>
<json:string>renal dialysis</json:string>
<json:string>renal disease</json:string>
<json:string>nephrogenic fibrosing dermopathy</json:string>
<json:string>plasmacytoid dendritic cells</json:string>
<json:string>virus infection</json:string>
<json:string>papillomatous surface</json:string>
<json:string>many tumours</json:string>
<json:string>clinical features</json:string>
<json:string>various sizes</json:string>
<json:string>cytoplasmic expression</json:string>
<json:string>atrophic plaques</json:string>
<json:string>inner right thigh</json:string>
<json:string>liver kidney</json:string>
<json:string>david geffen school</json:string>
<json:string>palo alto</json:string>
<json:string>peculiar type</json:string>
<json:string>trichilemmal keratinization</json:string>
<json:string>dystrophic calcinosis cutis</json:string>
<json:string>haemorrhagic cystitis</json:string>
<json:string>epidermal keratins</json:string>
<json:string>labia majora</json:string>
<json:string>genital mucosa</json:string>
<json:string>granular cell layer</json:string>
<json:string>small number</json:string>
<json:string>correspondence figure</json:string>
<json:string>residual keratinocytes</json:string>
<json:string>keratinizing differentiation</json:string>
<json:string>supraclavicular region</json:string>
<json:string>xanthomatous cells</json:string>
<json:string>seasonal factors</json:string>
<json:string>vaginal calculi</json:string>
<json:string>brown macules</json:string>
<json:string>oral pathol</json:string>
<json:string>adult patients</json:string>
<json:string>trichilemmal cyst</json:string>
<json:string>pediatr dermatol</json:string>
<json:string>pilot study</json:string>
<json:string>clinical practice</json:string>
<json:string>hydroxychloroquine sulphate</json:string>
<json:string>rare disease</json:string>
<json:string>severe multicentric reticulohistiocytosis</json:string>
<json:string>renal transplant</json:string>
<json:string>infectious diseases</json:string>
<json:string>trichilemmal tumor</json:string>
<json:string>medical dermatology</json:string>
<json:string>hospital admission</json:string>
<json:string>blood serology</json:string>
<json:string>common cutaneous</json:string>
<json:string>lupus erythematosus</json:string>
<json:string>pinkish erythematous papules</json:string>
<json:string>tacrolimus ointment</json:string>
<json:string>reticular erythematous mucinosis syndrome</json:string>
<json:string>urine analysis</json:string>
<json:string>relapse biopsies</json:string>
<json:string>bone densitometry</json:string>
<json:string>lesional biopsy</json:string>
<json:string>world health organisation</json:string>
<json:string>case report</json:string>
<json:string>centre</json:string>
<json:string>hepatitis</json:string>
</teeft>
</keywords>
<author>
<json:item>
<name>T. Petrella</name>
<affiliations>
<json:string>Centre de Pathologie, 33 Rue Nicolas Bornier, BP 189, and Laboratoire d'Anatomie Pathologique (Centre Hospitalo‐Universitaire), Dijon 21000, France, Departments of Pathology and Pediatrics, Center for Cell Mimetic Studies (CMISE), Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095‐1732, U.S.A.</json:string>
</affiliations>
</json:item>
<json:item>
<name>M.A. Teitell</name>
<affiliations>
<json:string>Centre de Pathologie, 33 Rue Nicolas Bornier, BP 189, and Laboratoire d'Anatomie Pathologique (Centre Hospitalo‐Universitaire), Dijon 21000, France, Departments of Pathology and Pediatrics, Center for Cell Mimetic Studies (CMISE), Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095‐1732, U.S.A.</json:string>
</affiliations>
</json:item>
<json:item>
<name>C. Spiekermann</name>
<affiliations>
<json:string>Pathology</json:string>
</affiliations>
</json:item>
<json:item>
<name>C.J.L.M. Meijer</name>
<affiliations>
<json:string>Department of Pathology, Vrije Universiteit Medical Centre, Amsterdam 1007MB, the Netherlands</json:string>
</affiliations>
</json:item>
<json:item>
<name>F. Franck</name>
<affiliations>
<json:string>Department of Pathology, Hotel Dieu, Clermont‐Ferrand 63000, France E‐mail: tony.petrella@centre‐de‐pathologie.fr</json:string>
</affiliations>
</json:item>
<json:item>
<name>I. Enache</name>
<affiliations>
<json:string>Internal Medicine, Centre Hospitalier Régional, Nevers 58000, France</json:string>
</affiliations>
</json:item>
</author>
<articleId>
<json:string>BJD5713</json:string>
</articleId>
<arkIstex>ark:/67375/WNG-73SRQHV7-W</arkIstex>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>letter</json:string>
</originalGenre>
<qualityIndicators>
<score>7.012</score>
<pdfWordCount>14247</pdfWordCount>
<pdfCharCount>92037</pdfCharCount>
<pdfVersion>1.4</pdfVersion>
<pdfPageCount>23</pdfPageCount>
<pdfPageSize>595 x 782 pts</pdfPageSize>
<pdfWordsPerPage>619</pdfWordsPerPage>
<pdfText>true</pdfText>
<refBibsNative>true</refBibsNative>
<abstractWordCount>1</abstractWordCount>
<abstractCharCount>0</abstractCharCount>
<keywordCount>0</keywordCount>
</qualityIndicators>
<title>A CD56‐negative case of blastic natural killer‐cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm)</title>
<pmid>
<json:string>14746651</json:string>
</pmid>
<genre>
<json:string>review-article</json:string>
</genre>
<host>
<title>British Journal of Dermatology</title>
<language>
<json:string>unknown</json:string>
</language>
<doi>
<json:string>10.1111/(ISSN)1365-2133</json:string>
</doi>
<issn>
<json:string>0007-0963</json:string>
</issn>
<eissn>
<json:string>1365-2133</json:string>
</eissn>
<publisherId>
<json:string>BJD</json:string>
</publisherId>
<volume>150</volume>
<issue>1</issue>
<pages>
<first>174</first>
<last>176</last>
<total>3</total>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
</host>
<namedEntities>
<unitex>
<date>
<json:string>from January 1995 to December 1998</json:string>
<json:string>2004</json:string>
</date>
<geogName></geogName>
<orgName>
<json:string>Osaka City University</json:string>
</orgName>
<orgName_funder></orgName_funder>
<orgName_provider></orgName_provider>
<persName>
<json:string>A.Zeghnoun</json:string>
<json:string>Pascal Joly</json:string>
<json:string>P.Joly</json:string>
<json:string>A.Macario</json:string>
<json:string>Charles Nicolle</json:string>
<json:string>L.Froment</json:string>
</persName>
<placeName></placeName>
<ref_url></ref_url>
<ref_bibl>
<json:string>Ronnen et al.</json:string>
</ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark>
<json:string>ark:/67375/WNG-73SRQHV7-W</json:string>
</ark>
<categories>
<wos>
<json:string>1 - science</json:string>
<json:string>2 - dermatology</json:string>
</wos>
<scienceMetrix>
<json:string>1 - health sciences</json:string>
<json:string>2 - clinical medicine</json:string>
<json:string>3 - dermatology & venereal diseases</json:string>
</scienceMetrix>
<scopus>
<json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Dermatology</json:string>
</scopus>
</categories>
<publicationDate>2004</publicationDate>
<copyrightDate>2004</copyrightDate>
<doi>
<json:string>10.1111/j.1365-2133.2004.05713.x</json:string>
</doi>
<id>F3844CBE1D15EA603339F7C3304503BF5D105C79</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-73SRQHV7-W/fulltext.pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-73SRQHV7-W/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-73SRQHV7-W/fulltext.tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main">A CD56‐negative case of blastic natural killer‐cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm)</title>
<title level="a" type="short">CORRESPONDENCE</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2004-01"></date>
</publicationStmt>
<notesStmt>
<note type="content-type" subtype="review-article" source="letter" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</note>
<note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
</notesStmt>
<sourceDesc>
<biblStruct type="review-article">
<analytic>
<title level="a" type="main">A CD56‐negative case of blastic natural killer‐cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm)</title>
<title level="a" type="short">CORRESPONDENCE</title>
<author xml:id="author-0000">
<persName>
<forename type="first">T.</forename>
<surname>Petrella</surname>
</persName>
<affiliation>
<orgName type="division">Centre de Pathologie</orgName>
<address>
<addrLine>33 Rue Nicolas Bornier</addrLine>
<addrLine>BP 189, and Laboratoire d'Anatomie Pathologique (Centre Hospitalo‐Universitaire), Dijon 21000, France, Departments of Pathology and Pediatrics, Center for Cell Mimetic Studies (CMISE), Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095‐1732, U.S.A.</addrLine>
</address>
</affiliation>
</author>
<author xml:id="author-0001">
<persName>
<forename type="first">M.A.</forename>
<surname>Teitell</surname>
</persName>
<affiliation>
<orgName type="division">Centre de Pathologie</orgName>
<address>
<addrLine>33 Rue Nicolas Bornier</addrLine>
<addrLine>BP 189, and Laboratoire d'Anatomie Pathologique (Centre Hospitalo‐Universitaire), Dijon 21000, France, Departments of Pathology and Pediatrics, Center for Cell Mimetic Studies (CMISE), Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095‐1732, U.S.A.</addrLine>
</address>
</affiliation>
</author>
<author xml:id="author-0002">
<persName>
<forename type="first">C.</forename>
<surname>Spiekermann</surname>
</persName>
<affiliation>
<orgName type="department">Pathology</orgName>
</affiliation>
</author>
<author xml:id="author-0003">
<persName>
<forename type="first">C.J.L.M.</forename>
<surname>Meijer</surname>
</persName>
<affiliation>
<orgName type="department">Department of Pathology</orgName>
<orgName type="institution">Vrije Universiteit Medical Centre</orgName>
<address>
<addrLine>Amsterdam 1007MB</addrLine>
<addrLine>the Netherlands</addrLine>
<country key="NL" xml:lang="en">THE NETHERLANDS</country>
</address>
</affiliation>
</author>
<author xml:id="author-0004">
<persName>
<forename type="first">F.</forename>
<surname>Franck</surname>
</persName>
<affiliation>
<orgName type="department">Department of Pathology</orgName>
<address>
<addrLine>Hotel Dieu</addrLine>
<addrLine>Clermont‐Ferrand 63000, France E‐mail: tony.petrella@centre‐de‐pathologie.fr</addrLine>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<author xml:id="author-0005">
<persName>
<forename type="first">I.</forename>
<surname>Enache</surname>
</persName>
<affiliation>
<address>
<addrLine>Internal Medicine</addrLine>
<addrLine>Centre Hospitalier Régional, Nevers 58000, France</addrLine>
<country key="FR" xml:lang="en">FRANCE</country>
</address>
</affiliation>
</author>
<idno type="istex">F3844CBE1D15EA603339F7C3304503BF5D105C79</idno>
<idno type="ark">ark:/67375/WNG-73SRQHV7-W</idno>
<idno type="DOI">10.1111/j.1365-2133.2004.05713.x</idno>
<idno type="unit">BJD5713</idno>
<idno type="toTypesetVersion">file:BJD.BJD5713.pdf</idno>
</analytic>
<monogr>
<title level="j" type="main">British Journal of Dermatology</title>
<title level="j" type="alt">BRITISH JOURNAL OF DERMATOLOGY</title>
<idno type="pISSN">0007-0963</idno>
<idno type="eISSN">1365-2133</idno>
<idno type="book-DOI">10.1111/(ISSN)1365-2133</idno>
<idno type="book-part-DOI">10.1111/bjd.2004.150.issue-1</idno>
<idno type="product">BJD</idno>
<idno type="publisherDivision">ST</idno>
<imprint>
<biblScope unit="vol">150</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="174">174</biblScope>
<biblScope unit="page" to="176">176</biblScope>
<biblScope unit="page-count">3</biblScope>
<publisher>Blackwell Science Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2004-01"></date>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<encodingDesc>
<schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef>
<appInfo>
<application ident="pub2tei" version="1.0.10" when="2019-12-20">
<label>pub2TEI-ISTEX</label>
<desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref>
</desc>
</application>
</appInfo>
</encodingDesc>
<revisionDesc>
<change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-73SRQHV7-W/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Blackwell Science Ltd</publisherName>
<publisherLoc>Oxford, UK</publisherLoc>
</publisherInfo>
<doi origin="wiley" registered="yes">10.1111/(ISSN)1365-2133</doi>
<issn type="print">0007-0963</issn>
<issn type="electronic">1365-2133</issn>
<idGroup>
<id type="product" value="BJD"></id>
<id type="publisherDivision" value="ST"></id>
</idGroup>
<titleGroup>
<title type="main" sort="BRITISH JOURNAL OF DERMATOLOGY">British Journal of Dermatology</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="01001">
<doi origin="wiley">10.1111/bjd.2004.150.issue-1</doi>
<numberingGroup>
<numbering type="journalVolume" number="150">150</numbering>
<numbering type="journalIssue" number="1">1</numbering>
</numberingGroup>
<coverDate startDate="2004-01">January 2004</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="letter" position="0017400" status="forIssue">
<doi origin="wiley">10.1111/j.1365-2133.2004.05713.x</doi>
<idGroup>
<id type="unit" value="BJD5713"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="3"></count>
</countGroup>
<titleGroup>
<title type="tocHeading1">Correspondence</title>
</titleGroup>
<eventGroup>
<event type="firstOnline" date="2004-01-26"></event>
<event type="publishedOnlineFinalForm" date="2004-01-26"></event>
<event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.2 mode:FullText source:FullText result:FullText" date="2010-03-08"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-15"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-15"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst" number="174">174</numbering>
<numbering type="pageLast" number="176">176</numbering>
</numberingGroup>
<linkGroup>
<link type="toTypesetVersion" href="file:BJD.BJD5713.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<countGroup>
<count type="figureTotal" number="2"></count>
<count type="tableTotal" number="0"></count>
<count type="formulaTotal" number="0"></count>
<count type="referenceTotal" number="10"></count>
<count type="wordTotal" number="806"></count>
<count type="linksPubMed" number="0"></count>
<count type="linksCrossRef" number="0"></count>
</countGroup>
<titleGroup>
<title type="main">A CD56‐negative case of blastic natural killer‐cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm)</title>
<title type="short">CORRESPONDENCE</title>
</titleGroup>
<creators>
<creator creatorRole="author" xml:id="cr1" affiliationRef="#a1">
<personName>
<givenNames>T.</givenNames>
<familyName>Petrella</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr2" affiliationRef="#a1">
<personName>
<givenNames>M.A.</givenNames>
<familyName>Teitell</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr3" affiliationRef="#a2">
<personName>
<givenNames>C.</givenNames>
<familyName>Spiekermann</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr4" affiliationRef="#a3">
<personName>
<givenNames>C.J.L.M.</givenNames>
<familyName>Meijer</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr5" affiliationRef="#a4">
<personName>
<givenNames>F.</givenNames>
<familyName>Franck</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="cr6" affiliationRef="#a5">
<personName>
<givenNames>I.</givenNames>
<familyName>Enache</familyName>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="a1">
<unparsedAffiliation>Centre de Pathologie, 33 Rue Nicolas Bornier, BP 189, and Laboratoire d'Anatomie Pathologique (Centre Hospitalo‐Universitaire), Dijon 21000, France, Departments of Pathology and Pediatrics, Center for Cell Mimetic Studies (CMISE), Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095‐1732, U.S.A.</unparsedAffiliation>
</affiliation>
<affiliation xml:id="a2">
<unparsedAffiliation>Pathology</unparsedAffiliation>
</affiliation>
<affiliation xml:id="a5" countryCode="FR">
<unparsedAffiliation>Internal Medicine, Centre Hospitalier Régional, Nevers 58000, France</unparsedAffiliation>
</affiliation>
<affiliation xml:id="a3" countryCode="NL">
<unparsedAffiliation>Department of Pathology, Vrije Universiteit Medical Centre, Amsterdam 1007MB, the Netherlands</unparsedAffiliation>
</affiliation>
<affiliation xml:id="a4" countryCode="FR">
<unparsedAffiliation>Department of Pathology, Hotel Dieu, Clermont‐Ferrand 63000, France E‐mail:
<email normalForm="tony.petrella@centre-de-pathologie.fr">tony.petrella@centre‐de‐pathologie.fr</email>
</unparsedAffiliation>
</affiliation>
</affiliationGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>A CD56‐negative case of blastic natural killer‐cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm)</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>CORRESPONDENCE</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>A CD56‐negative case of blastic natural killer‐cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm)</title>
</titleInfo>
<name type="personal">
<namePart type="given">T.</namePart>
<namePart type="family">Petrella</namePart>
<affiliation>Centre de Pathologie, 33 Rue Nicolas Bornier, BP 189, and Laboratoire d'Anatomie Pathologique (Centre Hospitalo‐Universitaire), Dijon 21000, France, Departments of Pathology and Pediatrics, Center for Cell Mimetic Studies (CMISE), Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095‐1732, U.S.A.</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M.A.</namePart>
<namePart type="family">Teitell</namePart>
<affiliation>Centre de Pathologie, 33 Rue Nicolas Bornier, BP 189, and Laboratoire d'Anatomie Pathologique (Centre Hospitalo‐Universitaire), Dijon 21000, France, Departments of Pathology and Pediatrics, Center for Cell Mimetic Studies (CMISE), Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095‐1732, U.S.A.</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">C.</namePart>
<namePart type="family">Spiekermann</namePart>
<affiliation>Pathology</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">C.J.L.M.</namePart>
<namePart type="family">Meijer</namePart>
<affiliation>Department of Pathology, Vrije Universiteit Medical Centre, Amsterdam 1007MB, the Netherlands</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">F.</namePart>
<namePart type="family">Franck</namePart>
<affiliation>Department of Pathology, Hotel Dieu, Clermont‐Ferrand 63000, France E‐mail: tony.petrella@centre‐de‐pathologie.fr</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">I.</namePart>
<namePart type="family">Enache</namePart>
<affiliation>Internal Medicine, Centre Hospitalier Régional, Nevers 58000, France</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="review-article" displayLabel="letter" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</genre>
<originInfo>
<publisher>Blackwell Science Ltd</publisher>
<place>
<placeTerm type="text">Oxford, UK</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2004-01</dateIssued>
<copyrightDate encoding="w3cdtf">2004</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<extent unit="figures">2</extent>
<extent unit="tables">0</extent>
<extent unit="formulas">0</extent>
<extent unit="references">10</extent>
<extent unit="linksCrossRef">0</extent>
<extent unit="words">806</extent>
</physicalDescription>
<relatedItem type="host">
<titleInfo>
<title>British Journal of Dermatology</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<identifier type="ISSN">0007-0963</identifier>
<identifier type="eISSN">1365-2133</identifier>
<identifier type="DOI">10.1111/(ISSN)1365-2133</identifier>
<identifier type="PublisherID">BJD</identifier>
<part>
<date>2004</date>
<detail type="volume">
<caption>vol.</caption>
<number>150</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>1</number>
</detail>
<extent unit="pages">
<start>174</start>
<end>176</end>
<total>3</total>
</extent>
</part>
</relatedItem>
<relatedItem type="references" displayLabel="cit1">
<titleInfo>
<title>Blastic natural killer cell and extranodal natural killer cell‐like T‐cell lymphoma presenting in the skin: report of six cases from the U.K</title>
</titleInfo>
<name type="personal">
<namePart type="given">FJ</namePart>
<namePart type="family">Child</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">TJ</namePart>
<namePart type="family">Mitchell</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">SJ</namePart>
<namePart type="family">Whittaker</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Child FJ, Mitchell TJ, Whittaker SJ et al. Blastic natural killer cell and extranodal natural killer cell‐like T‐cell lymphoma presenting in the skin: report of six cases from the U.K. Br J Dermatol 2003; 148: 507–15.</note>
<part>
<date>2003</date>
<detail type="volume">
<caption>vol.</caption>
<number>148</number>
</detail>
<extent unit="pages">
<start>507</start>
<end>15</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Br J Dermatol</title>
</titleInfo>
<part>
<date>2003</date>
<detail type="volume">
<caption>vol.</caption>
<number>148</number>
</detail>
<extent unit="pages">
<start>507</start>
<end>15</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit2">
<titleInfo>
<title>CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Étude des Lymphomes Cutanés (GFELC)</title>
</titleInfo>
<name type="personal">
<namePart type="given">T</namePart>
<namePart type="family">Petrella</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">S</namePart>
<namePart type="family">Dalac</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M</namePart>
<namePart type="family">Maynadie</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Petrella T, Dalac S, Maynadie M et al. CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Étude des Lymphomes Cutanés (GFELC). Am J Surg Pathol 1999; 23: 137–46.</note>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>23</number>
</detail>
<extent unit="pages">
<start>137</start>
<end>46</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Am J Surg Pathol</title>
</titleInfo>
<part>
<date>1999</date>
<detail type="volume">
<caption>vol.</caption>
<number>23</number>
</detail>
<extent unit="pages">
<start>137</start>
<end>46</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit3">
<titleInfo>
<title>New CD56 positive and cytotoxic T‐cell cutaneous lymphomas from the World Health Organisation</title>
</titleInfo>
<name type="personal">
<namePart type="given">DN</namePart>
<namePart type="family">Slater</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Slater DN. New CD56 positive and cytotoxic T‐cell cutaneous lymphomas from the World Health Organisation. Br J Dermatol 2003; 148: 385–7.</note>
<part>
<date>2003</date>
<detail type="volume">
<caption>vol.</caption>
<number>148</number>
</detail>
<extent unit="pages">
<start>385</start>
<end>7</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Br J Dermatol</title>
</titleInfo>
<part>
<date>2003</date>
<detail type="volume">
<caption>vol.</caption>
<number>148</number>
</detail>
<extent unit="pages">
<start>385</start>
<end>7</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit4">
<titleInfo>
<title>Blastic NK‐cell lymphoma</title>
</titleInfo>
<name type="personal">
<namePart type="given">JKC</namePart>
<namePart type="family">Chan</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">ES</namePart>
<namePart type="family">Jaffe</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">E</namePart>
<namePart type="family">Ralfkiaer</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>book-chapter</genre>
<relatedItem type="host">
<titleInfo>
<title>The World Health Organisation Classification of Tumors: Tumors of Hematopoietic and Lymphoid Tissues</title>
</titleInfo>
<originInfo>
<publisher>IARC Press</publisher>
</originInfo>
<part>
<date>2001</date>
<extent unit="pages">
<start>214</start>
<end>5</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit5">
<titleInfo>
<title>‘Agranular CD4+ CD56+ hematodermic neoplasm’ (blastic NK‐cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes</title>
</titleInfo>
<name type="personal">
<namePart type="given">T</namePart>
<namePart type="family">Petrella</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">MR</namePart>
<namePart type="family">Comeau</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">M</namePart>
<namePart type="family">Maynadie</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Petrella T, Comeau MR, Maynadie M et al. ‘Agranular CD4+ CD56+ hematodermic neoplasm’ (blastic NK‐cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002; 26: 852–62.</note>
<part>
<date>2002</date>
<detail type="volume">
<caption>vol.</caption>
<number>26</number>
</detail>
<extent unit="pages">
<start>852</start>
<end>62</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Am J Surg Pathol</title>
</titleInfo>
<part>
<date>2002</date>
<detail type="volume">
<caption>vol.</caption>
<number>26</number>
</detail>
<extent unit="pages">
<start>852</start>
<end>62</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit6">
<titleInfo>
<title>Identification of a leukemic counterpart of the plasmacytoid dendritic cells</title>
</titleInfo>
<name type="personal">
<namePart type="given">L</namePart>
<namePart type="family">Chaperot</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">N</namePart>
<namePart type="family">Bendriss</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">O</namePart>
<namePart type="family">Manches</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Chaperot L, Bendriss N, Manches O et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001; 97: 3210–7.</note>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>97</number>
</detail>
<extent unit="pages">
<start>3210</start>
<end>7</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Blood</title>
</titleInfo>
<part>
<date>2001</date>
<detail type="volume">
<caption>vol.</caption>
<number>97</number>
</detail>
<extent unit="pages">
<start>3210</start>
<end>7</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit7">
<titleInfo>
<title>Clinical and biologic features of CD4(+)CD56(+) malignancies</title>
</titleInfo>
<name type="personal">
<namePart type="given">J</namePart>
<namePart type="family">Feuillard</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">MC</namePart>
<namePart type="family">Jacob</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">F</namePart>
<namePart type="family">Valensi</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Feuillard J, Jacob MC, Valensi F et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood 2002; 99: 1556–63.</note>
<part>
<date>2002</date>
<detail type="volume">
<caption>vol.</caption>
<number>99</number>
</detail>
<extent unit="pages">
<start>1556</start>
<end>63</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Blood</title>
</titleInfo>
<part>
<date>2002</date>
<detail type="volume">
<caption>vol.</caption>
<number>99</number>
</detail>
<extent unit="pages">
<start>1556</start>
<end>63</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit8">
<titleInfo>
<title>TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+CD56+ blastic tumors of skin</title>
</titleInfo>
<name type="personal">
<namePart type="given">M</namePart>
<namePart type="family">Herling</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">MA</namePart>
<namePart type="family">Teitell</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">RR</namePart>
<namePart type="family">Shen</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Herling M, Teitell MA, Shen RR et al. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+CD56+ blastic tumors of skin. Blood 2003; 101: 5007–9.</note>
<part>
<date>2003</date>
<detail type="volume">
<caption>vol.</caption>
<number>101</number>
</detail>
<extent unit="pages">
<start>5007</start>
<end>9</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Blood</title>
</titleInfo>
<part>
<date>2003</date>
<detail type="volume">
<caption>vol.</caption>
<number>101</number>
</detail>
<extent unit="pages">
<start>5007</start>
<end>9</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit9">
<titleInfo>
<title>In vivo generation of human dendritic cell subsets by Flt3 ligand</title>
</titleInfo>
<name type="personal">
<namePart type="given">E</namePart>
<namePart type="family">Maraskovsky</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">E</namePart>
<namePart type="family">Daro</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">E</namePart>
<namePart type="family">Roux</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Maraskovsky E, Daro E, Roux E et al. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 2000; 96: 878–84.</note>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>96</number>
</detail>
<extent unit="pages">
<start>878</start>
<end>84</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Blood</title>
</titleInfo>
<part>
<date>2000</date>
<detail type="volume">
<caption>vol.</caption>
<number>96</number>
</detail>
<extent unit="pages">
<start>878</start>
<end>84</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<relatedItem type="references" displayLabel="cit10">
<titleInfo>
<title>Anti‐high endothelial venule monoclonal antibody HECA‐452 recognizes plasmacytoid T cells and delineates an ‘extranodular’ compartment in the reactive lymph node</title>
</titleInfo>
<name type="personal">
<namePart type="given">F</namePart>
<namePart type="family">Facchetti</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">C</namePart>
<namePart type="family">De Wolf‐Peeters</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">JJ</namePart>
<namePart type="family">Van Den Oord</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<genre>journal-article</genre>
<note type="citation/reference">Facchetti F, De Wolf‐Peeters C, Van Den Oord JJ et al. Anti‐high endothelial venule monoclonal antibody HECA‐452 recognizes plasmacytoid T cells and delineates an ‘extranodular’ compartment in the reactive lymph node. Immunol Lett 1989; 20: 277–81.</note>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>20</number>
</detail>
<extent unit="pages">
<start>277</start>
<end>81</end>
</extent>
</part>
<relatedItem type="host">
<titleInfo>
<title>Immunol Lett</title>
</titleInfo>
<part>
<date>1989</date>
<detail type="volume">
<caption>vol.</caption>
<number>20</number>
</detail>
<extent unit="pages">
<start>277</start>
<end>81</end>
</extent>
</part>
</relatedItem>
</relatedItem>
<identifier type="istex">F3844CBE1D15EA603339F7C3304503BF5D105C79</identifier>
<identifier type="ark">ark:/67375/WNG-73SRQHV7-W</identifier>
<identifier type="DOI">10.1111/j.1365-2133.2004.05713.x</identifier>
<identifier type="ArticleID">BJD5713</identifier>
<accessCondition type="use and reproduction" contentType="copyright">© Wiley. All rights reserved.</accessCondition>
<recordInfo>
<recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource>
<recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin>
<recordCreationDate encoding="w3cdtf">2019-11-13</recordCreationDate>
</recordInfo>
</mods>
<json:item>
<extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/WNG-73SRQHV7-W/record.json</uri>
</json:item>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F85 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000F85 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:F3844CBE1D15EA603339F7C3304503BF5D105C79
   |texte=   A CD56‐negative case of blastic natural killer‐cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm)
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021